Pharmaceutical drugs.
Ended Awarded Last action
- Contract number
- 36C26022F0114
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $184,250
Award facts
- Contract value 100% obligated
- $184,644.74 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$131,889 | |
| Funding Only Action | $157,872 | |
| Supplemental Agreement for work within scope | $395 | |
| Original award | $157,872 |
About this award
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed price delivery order contract valued at $184,644.74 to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract, which is not set-aside, falls under Takeda's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs. The primary products being delivered are the oncology medications ICLUSIG (ponatinib) and NINLARO (ixazomib) capsules, to support healthcare programs serving veterans nationwide across the VA's integrated service networks. In addition to this specific delivery order, Takeda holds a larger $13 million single-award blanket purchase agreement (BPA) with the VA National Acquisition Center to provide ICLUSIG (ponatinib) through October 2024, also under the GSA Pharmaceuticals and Drugs contract vehicle.
Quick answers
Who was awarded contract 36C26022F0114?
36C26022F0114 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 6, 2022.
How much is contract 36C26022F0114 worth?
The government has obligated $184,250 on 36C26022F0114. Its current value, with exercised options, is $184,645.
Is contract 36C26022F0114 an order under another contract?
Yes. 36C26022F0114 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26022F0114 competed?
The extent of competition for 36C26022F0114 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award